Qing Qin Selected Research

Colonic Neoplasms (Colon Cancer)

2/2016

Adenomatous polyposis coli genotype-dependent toll-like receptor 4 activity in colon cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qing Qin Research Topics

Disease

11	Neoplasms (Cancer) 12/2022 - 01/2013
5	Myocardial Infarction 01/2023 - 08/2015
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 04/2010
4	Inflammation (Inflammations) 01/2021 - 02/2013
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2013
3	Neoplasm Metastasis (Metastasis) 09/2020 - 06/2015
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 05/2015
2	Ischemia 01/2023 - 07/2020
2	Thrombosis (Thrombus) 01/2023 - 01/2021
2	Breast Neoplasms (Breast Cancer) 09/2021 - 03/2014
2	Fibrosis (Cirrhosis) 01/2021 - 11/2018
2	Pathologic Constriction (Stenosis) 08/2016 - 01/2013
2	Carcinogenesis 02/2016 - 06/2015
2	Lung Neoplasms (Lung Cancer) 03/2014 - 03/2014
2	Hypoxia (Hypoxemia) 10/2013 - 01/2013
2	Non-alcoholic Fatty Liver Disease 02/2013 - 01/2013
1	Atherosclerosis 01/2023
1	Neointima 01/2023
1	Esophageal Neoplasms (Esophageal Cancer) 12/2022
1	Atherosclerotic Plaque (Atheroma) 01/2021
1	Death (Near-Death Experience) 01/2021
1	Dyspnea (Shortness of Breath) 07/2020
1	Heart Failure 07/2020
1	Arteriosclerosis 01/2020
1	Lentivirus Infections 01/2020
1	Acute Coronary Syndrome 01/2020
1	Radiation Pneumonitis 01/2020
1	Glioma (Gliomas) 04/2019
1	Glioblastoma (Glioblastoma Multiforme) 04/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Disease Progression 01/2019
1	Diabetes Mellitus 09/2018
1	Infections 01/2018
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 02/2016
1	Colonic Neoplasms (Colon Cancer) 02/2016
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 06/2015

Drug/Important Bio-Agent (IBA)

4	Phosphotransferases (Kinase)IBA 01/2019 - 01/2013
3	omega-Chloroacetophenone (Mace)IBA 01/2023 - 04/2010
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2015
2	MicroRNAs (MicroRNA)IBA 12/2022 - 04/2019
2	LigandsIBA 09/2021 - 01/2019
2	Eph Family Receptors (Eph Receptors)IBA 01/2021 - 01/2020
2	ProgranulinsIBA 01/2021 - 01/2020
2	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 05/2015
2	Peptides (Polypeptides)IBA 11/2018 - 03/2014
2	Insulin-Like Growth Factor I (IGF-1)IBA 09/2018 - 01/2014
2	Tyrosine Kinase InhibitorsIBA 06/2016 - 05/2015
2	Therapeutic UsesIBA 03/2014 - 02/2013
2	Interleukin-18 (Interleukin 18)IBA 02/2013 - 01/2013
2	QuercetinIBA 02/2013 - 01/2013
2	CytokinesIBA 02/2013 - 01/2013
1	Messenger RNA (mRNA)IBA 12/2022
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2022
1	CXC ChemokinesIBA 09/2021
1	Orphan Nuclear ReceptorsIBA 01/2021
1	EphA2 ReceptorIBA 01/2021
1	Gemcitabine FDA Link 09/2020
1	Capecitabine (Xeloda)FDA Link 09/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2020
1	InflammasomesIBA 01/2020
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2020
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	LuciferasesIBA 04/2019
1	Adenosine Triphosphate (ATP)IBA 04/2019
1	Glucose (Dextrose)FDA LinkGeneric 04/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	trametinibIBA 01/2019
1	dabrafenibIBA 01/2019
1	Glycogen Synthase KinasesIBA 11/2018
1	humaninIBA 11/2018
1	Insulin (Novolin)FDA Link 09/2018
1	Poly I-CIBA 01/2018
1	NucleotidesIBA 01/2018
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2018
1	Thrombospondin 1IBA 08/2016
1	Angiopoietin-2IBA 08/2016
1	EndostatinsIBA 08/2016
1	Gefitinib (Iressa)FDA Link 06/2016
1	Diphosphonates (Bisphosphonates)IBA 06/2016
1	Zoledronic Acid (Zometa)FDA Link 06/2016
1	Growth Factor ReceptorsIBA 06/2016
1	LipopolysaccharidesIBA 02/2016
1	Toll-Like Receptor 4IBA 02/2016
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2016
1	CateninsIBA 02/2016
1	Biomarkers (Surrogate Marker)IBA 06/2015
1	EnzymesIBA 06/2015
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2015
1	Endothelin-1 (Endothelin 1)IBA 12/2014

Therapy/Procedure

3	Radiotherapy 12/2022 - 04/2019
3	Therapeutics 01/2022 - 12/2013
3	Percutaneous Coronary Intervention 01/2022 - 01/2013
3	Drug Therapy (Chemotherapy) 06/2015 - 12/2013
2	Ligation 01/2023 - 01/2021
2	Stents 01/2021 - 01/2021
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 07/2020 - 01/2013
1	Length of Stay 01/2021
1	Adjuvant Chemoradiotherapy 09/2020